Review: Induced pluripotent stem cell models of frontotemporal dementia

Area of Science:

• Neuroscience
• Genetics
• Stem Cell Biology

Background:

• Dementia is a growing public health concern due to an aging population and limited treatment options.
• Understanding dementia's underlying mechanisms remains a challenge, hindering pharmacological intervention progress.
• Cellular reprogramming and genome engineering offer novel approaches for disease modeling.

Purpose of the Study:

• To review findings from induced pluripotent stem cell (iPSC)-based studies in frontotemporal dementia (FTD) and FTD overlapping with amyotrophic lateral sclerosis (FTD/ALS).
• To highlight the potential of iPSCs in elucidating pathogenic mechanisms of dementia.
• To discuss the application of iPSCs in accelerating drug discovery for neurodegenerative diseases.

Main Methods:

• Utilizing patient-derived induced pluripotent stem cells (iPSCs) to generate neurons in vitro.
• Analyzing iPSC-based disease models for frontotemporal dementia (FTD) and FTD/ALS.
• Reviewing recent scientific literature on iPSC applications in dementia research.

Main Results:

• iPSC technology enables the study of patient-specific neurons, advancing dementia research.
• Emerging iPSC models show promise for understanding complex neurodegenerative disease pathways.
• Studies using iPSCs are beginning to shed light on the mechanisms of FTD and FTD/ALS.

Conclusions:

• iPSC-based modeling represents a significant advancement for studying dementia and related disorders.
• This approach holds potential for uncovering disease mechanisms and facilitating the development of new dementia therapies.
• Challenges remain in applying iPSC technology to complex, late-onset neurodegenerative conditions.